190 related articles for article (PubMed ID: 22288441)
1. The long-term risk of malignancy following a diagnosis of coeliac disease or dermatitis herpetiformis: a cohort study.
Grainge MJ; West J; Solaymani-Dodaran M; Card TR; Logan RF
Aliment Pharmacol Ther; 2012 Mar; 35(6):730-9. PubMed ID: 22288441
[TBL] [Abstract][Full Text] [Related]
2. Malignancies and mortality in patients with coeliac disease and dermatitis herpetiformis: 30-year population-based study.
Viljamaa M; Kaukinen K; Pukkala E; Hervonen K; Reunala T; Collin P
Dig Liver Dis; 2006 Jun; 38(6):374-80. PubMed ID: 16627018
[TBL] [Abstract][Full Text] [Related]
3. Risk of malignancy in diagnosed coeliac disease: a 24-year prospective, population-based, cohort study.
Card TR; West J; Holmes GK
Aliment Pharmacol Ther; 2004 Oct; 20(7):769-75. PubMed ID: 15379837
[TBL] [Abstract][Full Text] [Related]
4. Malignancy and survival in dermatitis herpetiformis: a comparison with coeliac disease.
Collin P; Pukkala E; Reunala T
Gut; 1996 Apr; 38(4):528-30. PubMed ID: 8707082
[TBL] [Abstract][Full Text] [Related]
5. No increase in risk of fracture, malignancy or mortality in dermatitis herpetiformis: a cohort study.
Lewis NR; Logan RF; Hubbard RB; West J
Aliment Pharmacol Ther; 2008 Jun; 27(11):1140-7. PubMed ID: 18315580
[TBL] [Abstract][Full Text] [Related]
6. Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma.
Smedby KE; Akerman M; Hildebrand H; Glimelius B; Ekbom A; Askling J
Gut; 2005 Jan; 54(1):54-9. PubMed ID: 15591504
[TBL] [Abstract][Full Text] [Related]
7. Risk of second cancer after treatment of aggressive non-Hodgkin's lymphoma; an EORTC cohort study.
Moser EC; Noordijk EM; van Leeuwen FE; Baars JW; Thomas J; Carde P; Meerwaldt JH; van Glabbeke M; Kluin-Nelemans HC
Haematologica; 2006 Nov; 91(11):1481-8. PubMed ID: 17043014
[TBL] [Abstract][Full Text] [Related]
8. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M
Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
[TBL] [Abstract][Full Text] [Related]
9. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada.
MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Phillips N; McBride ML
Pediatr Blood Cancer; 2007 Apr; 48(4):453-9. PubMed ID: 16767718
[TBL] [Abstract][Full Text] [Related]
10. Malignancies in cases with screening-identified evidence of coeliac disease: a long-term population-based cohort study.
Lohi S; Mäki M; Montonen J; Knekt P; Pukkala E; Reunanen A; Kaukinen K
Gut; 2009 May; 58(5):643-7. PubMed ID: 18852259
[TBL] [Abstract][Full Text] [Related]
11. Mortality in people with coeliac disease: Long-term follow-up from a Scottish cohort.
Quarpong W; Card TR; West J; Solaymani-Dodaran M; Logan RF; Grainge MJ
United European Gastroenterol J; 2019 Apr; 7(3):377-387. PubMed ID: 31019706
[TBL] [Abstract][Full Text] [Related]
12. Incidence of cancer among patients with atopic dermatitis.
Hagströmer L; Ye W; Nyrén O; Emtestam L
Arch Dermatol; 2005 Sep; 141(9):1123-7. PubMed ID: 16172309
[TBL] [Abstract][Full Text] [Related]
13. Moderately increased risk of urinary stone disease in patients with biopsy-verified coeliac disease.
Ludvigsson JF; Zingone F; Fored M; Ciacci C; Cirillo M
Aliment Pharmacol Ther; 2012 Feb; 35(4):477-84. PubMed ID: 22221254
[TBL] [Abstract][Full Text] [Related]
14. Cancer incidence in blood transfusion recipients.
Hjalgrim H; Edgren G; Rostgaard K; Reilly M; Tran TN; Titlestad KE; Shanwell A; Jersild C; Adami J; Wikman A; Gridley G; Wideroff L; Nyrén O; Melbye M
J Natl Cancer Inst; 2007 Dec; 99(24):1864-74. PubMed ID: 18073377
[TBL] [Abstract][Full Text] [Related]
15. Risk of second malignancy after non-Hodgkin's lymphoma: a British Cohort Study.
Mudie NY; Swerdlow AJ; Higgins CD; Smith P; Qiao Z; Hancock BW; Hoskin PJ; Linch DC
J Clin Oncol; 2006 Apr; 24(10):1568-74. PubMed ID: 16520465
[TBL] [Abstract][Full Text] [Related]
16. Occupation and cancer - follow-up of 15 million people in five Nordic countries.
Pukkala E; Martinsen JI; Lynge E; Gunnarsdottir HK; Sparén P; Tryggvadottir L; Weiderpass E; Kjaerheim K
Acta Oncol; 2009; 48(5):646-790. PubMed ID: 19925375
[TBL] [Abstract][Full Text] [Related]
17. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
18. Liver transplantation and subsequent risk of cancer: findings from a Canadian cohort study.
Jiang Y; Villeneuve PJ; Fenton SS; Schaubel DE; Lilly L; Mao Y
Liver Transpl; 2008 Nov; 14(11):1588-97. PubMed ID: 18975293
[TBL] [Abstract][Full Text] [Related]
19. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
[TBL] [Abstract][Full Text] [Related]
20. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.
Mauch PM; Kalish LA; Marcus KC; Shulman LN; Krill E; Tarbell NJ; Silver B; Weinstein H; Come S; Canellos GP; Coleman CN
Cancer J Sci Am; 1995; 1(1):33-42. PubMed ID: 9166452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
